09 Aug Riata Defibrillator Ads Rise Following FDA Safety Notice
Mass tort law firms increased their spending on TV advertisements targeting users of the Riata Defibrillator by nearly 50% in June following a new FDA safety advisory about the device.
St. Jude Medical recalled the product in late 2011 due to the discovery of premature erosion of its electrical wires and, on June 3, the FDA noted that the device still remains implanted in thousands of patients.
The advertising law firms, lead by Ferrer, Poirot, & Wansbrough of Dallas, focused their ad spending on nearly 90 ads — like the one below — that aired on national broadcast network and cable TV.
As seen in the heat map, about 200 ads also ran in local media markets.